Tuesday, May 17th, 2016 - RnR Market Research

RnRMarketResearch.com adds Global Liver Cirrhosis Therapeutics Market 2016-2020 a new research reports in its store. The analysts forecast global liver cirrhosis therapeutics market to grow at a CAGR of 4.36% during the period 2016-2020.

Complete liver cirrhosis therapeutics market report is available at http://www.rnrmarketresearch.com/global-liver-cirrhosis-market-2016-2020-market-report.html .

Liver cirrhosis therapeutics market analyst said: "A noticeable trend in the market is the use of off-label drugs. Off-label drugs are unapproved medications that are used in the treatment of diseases. For instance, apart from multivitamins and mineral supplements, disulfiram, naltrexone, acamprosate, ciprofloxacin, norfloxacin, ceftriaxone, ofloxacin, amoxicillin-clavulanate, and phytonadione are among the off-label drugs available for the treatment of liver cirrhosis."

According to the report, a growth driver of this market is the high prevalence of liver cirrhosis. Alcohol has been identified as the strongest risk factor for liver cirrhosis, other than diabetes and hepatitis C, which together constitutes for over 50% of all cirrhosis cases. Relevant health efforts are required to reduce this disease burden, specifically among ethnic minorities and individuals living below the poverty level. As per a studies published, liver cirrhosis affects over 633,000 people every year. It also stated that more than 68% of these individuals may not know that they have the disease, raising the possibility of a large number of undiagnosed cases of liver cirrhosis.

Order a copy of Global Liver Cirrhosis Therapeutics Market 2016-2020, report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=542974 .

The report, Global Liver Cirrhosis Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Cirrhosis of the liver (or liver fibrosis) is a serious condition in which the liver stops functioning properly due to damage and irreversible scarring of the liver tissue. The scarring of the tissue is often caused by long-term exposure to viral infections and toxins such as alcohol. Chronic viral hepatitis and non-alcoholic steatohepatitis can also cause liver cirrhosis. Alcohol-related medications, antiviral medications, and metal chelating agents are used in the treatment of the causes of liver cirrhosis while antibiotics, vitamins, corticosteroids, diuretics, beta-blockers, and laxatives are used for the treatment of the complications of the disease.

Inquire for Discount @ http://www.rnrmarketresearch.com/contacts/discount?rname=542974 .

The report covers the present scenario and the growth prospects of the global liver cirrhosis therapeutics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of prescription, generic, and off-label drugs used in the treatment of liver cirrhosis.

Key players in the global liver cirrhosis therapeutics market: F Hoffman La-Roche, GlaxoSmithKline, Gilead Sciences, Johnson & Johnson, and Merck. Other Prominent Vendors in the market are: Bristol-Myers Squibb, Conatus Pharmaceuticals, Gwo Xi Stem Cell Applied Technology, Instituto Grifols, Intercept Pharmaceuticals, NGM Biopharmaceuticals, Norgine, Pharmicell, Salix Pharmaceuticals, and Stempeutics Research.

Further, the report states that a challenge that could impact market growth is the adverse effects of drugs used to treat this medical issue.

File Library

Contact Profile

RnR Market Research

About Us:  

RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Connect with Us: 

G+ / Google Plus: https://plus.google.com/104156468549256253075/posts

Twitter: https://twitter.com/RnRMR

Facebook: https://www.facebook.com/pages/RnR-Market-Research/413488545356345

RSS / Feeds: http://www.rnrmarketresearch.com/feed

Ritesh Tiwari
P: + 1 888 391 5441
W: www.rnrmarketresearch.com/


Liver Cirrhosis Therapeutics Market, Liver Cirrhosis Therapeutics Industry, Simulation Learning In Liver Cirrhosis Therapeutics Market Research Report, Liver Cirrhosis Therapeutics




More Formats